What is Rootine?
Rootine is a health technology company focused on transforming individual well-being through data-driven nutrition solutions. By analyzing a user's unique health data, Rootine identifies the specific nutritional needs required for optimal performance and then delivers tailored solutions. The company bridges the gap between complex biological information and actionable dietary recommendations, empowering individuals to understand and meet their body's precise requirements.
How much funding has Rootine raised?
Rootine has raised a total of $13M across 2 funding rounds:
Angel/Seed
$3M
Series A
$10M
Angel/Seed (2021): $3M with participation from Novogenia and DSM Venturing
Series A (2022): $10M led by Techstars, DSM Venturing, and Relevance Ventures
Key Investors in Rootine
Novogenia
Novogenia is an Austrian biotech firm specializing in preventive genetic testing and personalized health solutions, offering genetic analyses for health, beauty, and lifestyle, and supporting over 3,000 partners globally.
Techstars
Techstars is a global investment accelerator that supports entrepreneurs by connecting startups, investors, and corporations to foster thriving startup communities and drive innovation.
DSM Venturing
DSM Venturing is the venture capital arm of dsm-firmenich, investing in innovative startups within nutrition, health, and beauty, and actively partnering with entrepreneurs to drive market success.
What's next for Rootine?
The recent major strategic investment suggests Rootine is poised for significant scaling and market expansion. This capital infusion will likely fuel further technological development, enhance product offerings, and broaden its reach within the rapidly growing personalized health market. The company's focus on integrating health data with nutrition solutions positions it for continued growth and innovation in a sector increasingly driven by individual wellness insights.
See full Rootine company page
